Principles and emerging applications of nanomagnetic materials in medicine

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 4, Issue 4, 2012, Pages 345-365

  Clavijo Jordan, Veronica ^a   Kodibagkar, Vikram D ^a   Beeman, Scott C ^a   Hann, Bradley D ^a   Bennett, Kevin M ^a  

^a Arizona State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL APPLICATIONS; CANCER CELLS; EMERGING APPLICATIONS; MAGNETIC NANOMATERIALS; MEDICAL DIAGNOSTICS; NANO-METER SCALE; NANOMAGNETIC MATERIALS; NEW APPLICATIONS; NEW MECHANISMS; PHYSICAL MECHANISM; PHYSICAL SCIENCE; THERAPEUTIC TECHNIQUES; THERMAL ABLATION;

MAGNETIC MATERIALS; MEDICAL APPLICATIONS; MOLECULAR IMAGING; NANOMAGNETICS; TISSUE ENGINEERING;

INTERFACES (MATERIALS);

NANOMATERIAL;

ABLATION THERAPY; ARTICLE; CANCER CELL; CIRCULAR DICHROISM; CONJUGATION; CRYSTAL STRUCTURE; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; HIGH RESOLUTION ELECTRON MICROSCOPY; HUMAN; MAGNETIC PARTICLE IMAGING; MAGNETISM; MAGNETO OPTICAL KERR EFFECT MICROSCOPY; MOLECULAR IMAGING; NANOMEDICINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPIN POLARIZED ELECTRON MICROSCOPY; SQUID MAGNETOMETRY; SYNTHESIS; TISSUE ENGINEERING; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY MAGNETIC CIRCULAR DICHROISM;

ANIMALS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETICS; NANOMEDICINE; NANOSTRUCTURES;

EID: 84862640598     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1169     Document Type: Article

References (187)

1. Bean C, Livingston J. Superparamagnetism. J Appl Phy 1959, 30:S120-S159.
2. Krishnan KM. Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn 2010, 46:2523-2558.
3. Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phy D-Appl Phy 2003, 36:R167-R181.
4. Pankhurst QA, Thanh NKT, Jones SK, Dobson J. Progress in applications of magnetic nanoparticles in biomedicine. J Phy D-Appl Phy 2009, 42:224001-224015.
5. Guimaraes AP. Principles of Nanomagnetism. New York: Springer; 2009.
6. Pepperhoff W, Ancet M. Constitution and Magnetism of Iron And Its Alloys. New York: Springer; 2001.
7. Lee JH, Huh YM, Jun Y, Seo J, Jang J, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
8. Lutz JF, Stiller S, Hoth A, Kaufner L, Pison U, Cartier R. One-pot synthesis of pegylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents. Biomacromolecules 2006, 7:3132-3138.
9. Yu S, Chow GM. Synthesis of monodisperse iron oxide and iron/iron oxide core/shell nanoparticles via iron-oleylamine complex. J Nanosci Nanotechnol 2006, 6:2135-2140.
10. Sun SH, Zeng H. Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc 2002, 124: 8204-8205.
11. Park SJ, Kim S, Lee S, Khim ZG, Char K, Hyeon T. Synthesis and magnetic studies of uniform iron nanorods and nanospheres. J Am Chem Soc 2000, 122:8581-8582.
12. Puntes VF, Krishnan KM, Alivisatos AP. Colloidal nanocrystal shape and size control: the case of cobalt. Science 2001, 291:2115-2117.
13. Park JI, Cheon J. Synthesis of "solid solution" and "core-shell" type cobalt-platinum magnetic nanoparticles via transmetalation reactions. J Am Chem Soc 2001, 123:5743-5746.
14. Sun SH, Fullerton EE, Weller D, Murray CB. Compositionally controlled FePt nanoparticle materials. IEEE Trans Magn 2001, 37:1239-1243.
15. Park J, An KJ, Hwang YS, Park JG, Noh HJ, Kim JY, Park JH, Hwang NM, Hyeon T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3:891-895.
16. Chen Q, Rondinone AJ, Chakoumakos BC, Zhang ZJ. Synthesis of superparamagnetic MgFe2O4 nanoparticles by coprecipitation. J Magn Magn Mater 1999, 194:1-7.
17. Rondinone AJ, Samia ACS, Zhang ZJ. A Chemometric Approach for Predicting the Size of Magnetic Spinel Ferrite Nanoparticles from the Synthesis Conditions. J Phys Chem B 2000, 104:7919-7922.
18. Grasset F, Labhsetwar N, Li D, Park DC, Saito N, Haneda H, Cador O, Roisnel T, Mornet S, Duguet E, et al. Synthesis and magnetic characterization of zinc ferrite nanoparticles with different environments: powder, colloidal solution, and zinc ferrite-silica core-shell nanoparticles. Langmuir 2002, 18:8209-8216.
19. Neveu S, Bee A, Robineau M, Talbot D. Size-selective chemical synthesis of tartrate stabilized cobalt ferrite ionic magnetic fluid. J Colloid Interface Sci 2002, 255:293-298.
20. Hyeon T. Chemical synthesis of magnetic nanoparticles. Chem Commun (Camb) 2003, 34:927-934.
21. Lin XM, Samia ACS. Synthesis, assembly and physical properties of magnetic nanoparticles. J Magn Magn Mater 2006, 305:100-109.
22. Horak D, Babic M, Mackova H, Benes MJ. Preparation and properties of magnetic nano- and microsized particles for biological and environmental separations. J Sep Sci 2007, 30:1751-1772.
23. Lang C, Schuler D, Faivre D. Synthesis of magnetite nanoparticles for bio- and nanotechnology: genetic engineering and biomimetics of bacterial magnetosomes. Macromol Biosci 2007, 7:144-151.
24. Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 2007, 46:1222-1244.
25. Lam C, Zhang YF, Tang YH, Lee CS, Bello I, Lee ST. Large-scale synthesis of ultrafine Si nanoparticles by ball milling. J Cryst Growth 2000, 220:466-470.
26. Cojocaru P, Magagnin L, Gomez E, Valles E. Nanowires of NiCo/barium ferrite magnetic composite by electrodeposition. Mater Lett 2011, 65:2765-2768.
27. Bilecka I, Niederberger M. New developments in the nonaqueous and/or non-hydrolytic sol-gel synthesis of inorganic nanoparticles. Electrochimica Acta 2010, 55:7717-7725.
28. Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazu V, Borm P, Estrada G, Ntziachristos V, Razansky D. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol 2010, 7:3.
29. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006, 34:23-38.
30. Ganguli AK, Ganguly A, Vaidya S. Microemulsion-based synthesis of nanocrystalline materials. Chem Soc Rev 2010, 39:474-485.
31. Chen JP, Lee KM, Sorensen CM, Klabunde KJ, Hadjipanayis GC. Magnetic-properties of microemulsion synthesized cobalt fine particles. J Appl Phy 1994, 75:5876-5878.
32. Eastoe J, Robinson BH, Steytler DC, Thornleeson D. Structural studies of microemulsions stabilized by aerosol-Ot. Adv Colloid Interface Sci 1991, 36:1-31.
33. Pileni MP. Magnetic fluids: fabrication, magnetic properties, and organization of nanocrystals. Adv Funct Mater 2001, 11:323-336.
34. Seip CT, Carpenter EE, O'Connor CJ, John VT, Li SC. Magnetic properties of a series of ferrite nanoparticles synthesized in reverse micelles. IEEE Trans Magn 1998, 34:1111-1113.
35. Rondinone AJ, Samia ACS, Zhang ZJ. A chemometric approach for predicting the size of magnetic spinel ferrite nanoparticles from the synthesis conditions. J Phys Chem B 2000, 104:7919-7922.
36. Rondinone AJ, Samia ACS, Zhang ZJ. Superparamagnetic relaxation and magnetic anisotropy energy distribution in CoFe2O4 spinel ferrite nanocrystallites. J Phys Chem B 1999, 103:6876-6880.
37. Dinega DP, Bawendi MG. A solution-phase chemical approach to a new crystal structure of cobalt. Angew Chem Int Ed Engl 1999, 38:1788-1791.
38. Murray CB, Sun SH, Doyle H, Betley T. Monodisperse 3d transition-metal (Co, Ni, Fe) nanoparticles and their assembly into nanoparticle superlattices. MRS Bulletin 2001, 26:985-991.
39. Sun SH, Murray CB. Synthesis of monodisperse cobalt nanocrystals and their assembly into magnetic superlattices (invited). J Appl Phy 1999, 85:4325-4330.
40. Murray CB, Sun SH, Gaschler W, Doyle H, Betley TA, Kagan CR. Colloidal synthesis of nanocrystals and nanocrystal superlattices. IBM J Res Dev 2001, 45:47-56.
41. Chen M, Nikles DE. Synthesis of spherical FePd and CoPt nanoparticles. J Appl Phy 2002, 91:8477-8479.
42. Chen M, Nikles DE. Synthesis, self-assembly, and magnetic properties of FexCoyPt100-x-y nanoparticles. Nano Lett 2002, 2:211-214.
43. Zhou YF, Gulaka P, Zhou J, Xiao M, Xu DS, Hsieh JT, Kodibagkar VD, Sun XK. Preparation and evaluation of a radioisotope-incorporated iron oxide core/Au shell nanoplatform for dual modality imaging. J Biomed Nanotech 2008, 4:474-481.
44. Huang CW, Jiang JC, Muangphat C, Sun XK, Hao YW. Trapping iron oxide into hollow gold nanoparticles. Nanoscale Res Lett 2011, 6:43.
45. Liu J, Qiao SZ, Hu QH, Lu GQ. Magnetic nanocomposites with mesoporous structures: synthesis and applications. Small 2011, 7:425-443.
46. Uchida M, Terashima M, Cunningham CH, Suzuki Y, Willits DA, Willis AF, Yang PC, Tsao PS, McConnell MV, Young MJ, et al. A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med 2008, 60:1073-1081.
47. Bulte JW, Douglas T, Mann S, Frankel RB, Moskowitz BM, Brooks RA, Baumgarner CD, Vymazal J, Strub MP, Frank JA. Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J Magn Reson Imaging 1994, 4:497-505.
48. Wong KKW, Douglas T, Gider S, Awschalom DD, Mann S. Biomimetic synthesis and characterization of magnetic proteins (magnetoferritin). Chem Mater 1998, 10:279-285.
49. Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 2009, 1790:589-599.
50. Yang X, Chasteen ND. Ferroxidase activity of ferritin: effects of pH, buffer and Fe(II) and Fe(III) concentrations on Fe(II) autoxidation and ferroxidation. Biochem J 1999, 338(Pt 3):615-618.
51. Kalman FK, Geninatti-Crich S, Aime S. Reduction/dissolution of a β-MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agent. Angew Chem Int Ed Engl 2010, 49:612-615.
52. Aime S, Frullano L, Geninatti Crich S. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed Engl 2002, 41:1017-1019.
53. Vasalatiy O, Zhao P, Zhang S, Aime S, Sherry AD. Catalytic effects of apoferritin interior surface residues on water proton exchange in lanthanide complexes. Contrast Media Mol Imaging 2006, 1:10-14.
54. Park JI, Kang NJ, Jun YW, Oh SJ, Ri HC, Cheon J. Superlattice and magnetism directed by the size and shape of nanocrystals. Chemphyschem 2002, 3:543-547.
55. Park JI, Kim MG, Jun YW, Lee JS, Lee WR, Cheon J. Characterization of superparamagnetic "core-shell" nanoparticles and monitoring their anisotropic phase transition to ferromagnetic "solid solution" nanoalloys. J Am Chem Soc 2004, 126:9072-9078.
56. Allwood DA, Xiong G, Cooke MD, Cowburn RP. Magneto-optical Kerr effect analysis of magnetic nanostructures. J Phy D-Appl Phy 2003, 36: 2175-2182.
57. Stohr J. Exploring the microscopic origin of magnetic anisotropies with X-ray magnetic circular dichroism (XMCD) spectroscopy. J Magn Magn Mater 1999, 200:470-497.
58. Stohr J, Anders S. X-ray spectromicroscopy of complex materials and surfaces. IBM J Res Dev 2000, 44:535-551.
59. Brice-Profeta S, Arrio MA, Tronc E, Menguy N, Letard I, Moulin CCD, Nogues M, Chaneac C, Jolivet JP, Sainctavit P. Magnetic order in γ-Fe2O3 nanoparticles: a XMCD study. J Magn Magn Mater 2005, 288:354-365.
60. Sarkar A, Murugan AV, Manthiram A. Low cost Pd-W nanoalloy electrocatalysts for oxygen reduction reaction in fuel cells. J Mater Chem 2009, 19:159-165.
61. Janney DE, Cowley JM, Buseck PR. Structure of synthetic 2-line ferrihydrite by electron nanodiffraction. Am Mineral 2000, 85:1180-1187.
62. Clavijo Jordan V, Caplan MR, Bennett KM. Simplified synthesis and relaxometry of magnetoferritin for magnetic resonance imaging. Mang Reson Med 2010, 64:1260-1266.
63. Pierce DT. Spin-polarized electron microscopy. Physica Scripta 1988, 38:291-296.
64. Teruo K, Makoto K, Kazuyuki K. High-resolution spin-polarized scanning electron microscopy (spin SEM). J Electron Microsc 2010, 59:43-52.
65. Meldrum FC, Heywood BR, Mann S. Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science 1992, 257:522-523.
66. Brooks RA. T(2)-shortening by strongly magnetized spheres: a chemical exchange model. Magn Reson Med 2002, 47:388-391.
67. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994, 32:749-763.
68. Lee J, Sherlock SP, Terashima M, Kosuge H, Suzuki Y, Goodwin A, Robinson J, Seo W, Liu Z, Luong R, et al. High-contrast in vivo visualization of microvessels using novel FeCo/GC magnetic nanocrystals. Magn Reson Med 2009, 62:1497-1509.
69. Seo W, Lee J, Sun X, Suzuki Y, Mann D, Liu Z, Terashima M, Yang PC, McConnell MV, Nishimura DG, et al. FeCo/graphitic-shell nanocrystals as advanced magnetic resonance-imaging and near-infrared agents. Nat Mater 2006, 5:971-976.
70. Tromsdorf UI, Bigall NC, Kaul MG, Bruns OT, Nikolic MS, Mollwitz B, Sperling RA, Reimer R, Hohenberg H, Parak WJ, et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett 2007, 7:2422-2427.
71. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 2008, 3:133-149.
72. Douglas T, Young M. Viruses: making friends with old foes. Science 2006, 312:873-875.
73. Accardo A, Tesauro D, Morelli G, Gianolio E, Aime S, Vaccaro M, Mangiapia G, Paduano L, Schillén K. High-relaxivity supramolecular aggregates containing peptides and Gd complexes as contrast agents in MRI. J Biol Inorg Chem 2007, 12:267-276.
74. Karfeld LS, Bull SR, Davis NE, Meade TJ, Barron AE. Use of a genetically engineered protein for the design of a multivalent MRI contrast agent. Bioconjug Chem 2007, 18:1697-1700.
75. Song Y, Kohlmeir EK, Meade TJ. Synthesis of multimeric MR contrast agents for cellular imaging. J Am Chem Soc 2008, 130:6662-6663.
76. Sitharaman B, Kissell KR, Hartman KB, Tran LA, Baikalov A, Rusakova I, Sun Y, Khant HA, Ludtke SJ, Chiu W, et al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun (Camb) 2005, 31:3915-3917.
77. Miyawaki J, Yudasaka M, Imai H, Yorimitsu H, Isobe H, Nakamura E, Iijima S. Synthesis of ultrafine Gd2O3 nanoparticles inside single-wall carbon nanotubes. J Phys Chem B 2006, 110:5179-5181.
78. Choi JH, Nguyen FT, Barone PW, Heller DA, Moll AE, Patel D, Boppart SA, Strano MS. Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett 2007, 7:861-867.
79. Sitharaman B, Wilson LJ. Gadonanotubes as new high-performance MRI contrast agents. Int J Nanomed 2006, 1:291-295.
80. Faraj AA, Cieslar K, Lacroix G, Gaillard S, Canet-Soulas E, Cremillieux Y. In vivo imaging of carbon nanotube biodistribution using magnetic resonance imaging. Nano Lett 2009, 9:1023-1027.
81. Allen M, Bulte JW, Liepold L, Basu G, Zywicke HA, Frank JA, Young M, Douglas T. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med 2005, 54:807-812.
82. De Leon-Rodriguez LM, Lubag AJM, Malloy CR, Martinez GV, Gillies RJ, Sherry AD. Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res 2009, 42:948-957.
83. Querol M, Bogdanov A. Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs). J Magn Res Imaging 2006, 24:971-982.
84. Lowe MP, Parker D, Reany O, Aime S, Botta M, Castellano G, Gianolio E, Pagliarin R. pH-Dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc 2001, 123:7601-7609.
85. Ronald JA, Chen JW, Chen Y, Hamilton AM, Rodriguez E, Reynolds F, Hegele RA, Rogers KA, Querol M, Bogdanov A, et al. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation 2009, 120:592-599.
86. Raghunand N, Jagadish B, Trouard TP, Galons JP, Gillies RJ, Mash EA. Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin. Magn Reson Med 2006, 55:1272-1280.
87. Figueiredo S, Moreira JN, Geraldes C. Supramolecular protamine/Gd-loaded liposomes adducts as relaxometric protease responsive probes. Bioorg Med Chem 2010, 19:1131-1135.
88. Shapiro MG, Szablowski JO, Langer R, Jasanoff A. Protein nanoparticles engineered to sense kinase activity in MRI. J Am Chem Soc 2009, 131:2484-2486.
89. Yoo B, Raam MS, Rosenblum RM, Pagel MD. Enzyme-responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome. Contrast Media Mol Imaging 2007, 2:189-198.
90. Yoo B, Pagel MD. A PARACEST MRI contrast agent to detect enzyme activity. J AM Chem Soc 2006, 128:14032-14033.
91. Granot D, Shapiro EM. Release activation of iron oxide nanoparticles (REACTION): a novel environmentally sensitive MRI paradigm. Magn Reson Med 2011, 65:1253-1259.
92. Jastrzebska B, Lebel R, McIntyre OJ, Paquette B, Neugebauer W, Escher E, Lepage M. Monitoring of MMPs activity in vivo, non-invasively, using solubility switchable MRI contrast agent. Adv Exp Med Biol 2009, 611:453-454.
93. Jastrzebska B, Lebel R, Therriault H, McIntyre JO, Escher E, Guerin B, Paquette B, Neugebauer WA, Lepage M. New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging. J Med Chem 2009, 52:1576-1581.
94. Lebel R, Jastrzebska B, Therriault H, Cournoyer MM, McIntyre JO, Escher E, Neugebauer W, Paquette B, Lepage M. Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse model. Magn Reson Med 2008, 60:1056-1065.
95. Lepage M, Dow WC, Melchior M, You Y, Fingleton B, Quarles CC, Pepin C, Gore JC, Matrisian LM, McIntyre JO. Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Mol Imaging 2007, 6:393-403.
96. Hogain DO, Davies GR, Baroni S, Aime S, Lurie DJ. The use of contrast agents with fast field-cycling magnetic resonance imaging. Phys Med Biol 2011, 56:105-115.
97. Buxton RB, Wong EC, Frank LR. Dynamics of blood flow and oxygenation changes during brain activation: the balloon model. Magn Reson Med 1998, 39:855-864.
98. Glover GH. Deconvolution of impulse response in event-related BOLD fMRI. Neuroimage 1999, 9:416-429.
99. Amaro E, Barker GJ. Study design in fMRI: basic principles. Brain Cogn 2006, 60:220-232.
100. Jones CK, Bartha R, Menon RS. Sub-millimolar PARACEST detection using EPI-CEST. Proc Intl Soc Magn Reson Med 2007, 15:1763.
101. Osborne EA, Jarrett BR, Tu C, Louie AY. Modulation of T2 relaxation time by light-induced, reversible aggregation of magnetic nanoparticles. J Am Chem Soc 2010, 132:5934-5935.
102. Khemtong C, Togao O, Ren J, Kessinger CW, Takahashi M, Sherry AD, Gao J. Off-resonance saturation MRI of superparamagnetic nanoprobes: theoretical models and experimental validations. J Magn Reson 2011, 209:53-60.
103. Bennett KM, Shapiro EM, Sotak CH, Koretsky AP. Controlled aggregation of ferritin to modulate MRI relaxivity. Biophys J 2008, 95:342-351.
104. Zhao M, Josephson L, Tang Y, Weissleder R. Magnetic sensors for protease assays. Angew Chem Int Ed Engl 2003, 42:1375-1378.
105. Wunderbaldinger P, Josephson L, Weissleder R. Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad Radiol 2002, 9 (suppl 2):S304-S306.
106. Yoon TJ, Lee H, Shao H, Hilderbrand SA, Weissleder R. Multicore assemblies potentiate magnetic properties of biomagnetic nanoparticles. Adv Mater 2011, 23:4793-4797.
107. Gleich B, Weizenecker J. Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005, 435:1214-1217.
108. Gleich B, Weizenecker J, Borgert J. Experimental results on fast 2D-encoded magnetic particle imaging. Phys Med Biol 2008, 53:N81-N84.
109. Ferguson RM, Minard KR, Krishnan KM. Optimization of nanoparticle core size for magnetic particle imaging. J Magn Magn Mater 2009, 321:1548-1551.
110. Ferguson RM, Minard KR, Khandhar AP, Krishnan KM. Optimizing magnetite nanoparticles for mass sensitivity in magnetic particle imaging. Med Phys 2011, 38:1619-1626.
111. Weizenecker J, Gleich B, Rahmer J, Dahnke H, Borgert J. Three-dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 2009, 54:L1-L10.
112. Yoo D, Lee JH, Shin TH, Cheon J. Theranostic magnetic nanoparticles. Acc Chem Res 2011, 44:863-874.
113. Laurent S, Dutz S, Hafeli UO, Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Coll Interface Sci 2011, 166:8-23.
114. Williams SF, Lee WJ, Bender JG, Zimmerman T, Swinney P, Blake M, Carreon J, Schilling M, Smith S, Williams DE, et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996, 87:1687-1691.
115. Wang GY, Li Y, Yu YM, Yu B, Zhang ZY, Liu Y, Wang SJ. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting. J Gastroenterol Hepatol 2009, 24:299-306.
116. Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A, Oberneder R. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol 2003, 169:701-705.
117. Barry SE. Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperthermia 2008, 24:451-466.
118. Ivkov R, DeNardo SJ, Daum W, Foreman AR, Goldstein RC, Nemkov VS, DeNardo GL. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 2005, 11:7093s-7103s.
119. Lee JH, Jang JT, Choi JS, Moon SH, Noh SH, Kim JW, Kim JG, Kim IS, Park KI, Cheon J. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 2011, 6:418-422.
120. Ganguly R, Puri IK. Microfluidic transport in magnetic MEMS and bioMEMS. WIREs Nanomed Nanobiotechnol 2010, 2:382-399.
121. Roomans GM. Tissue engineering and the use of stem/progenitor cells for airway epithelium repair. Eur Cell Mater 2010, 19:284-299.
122. Gore JC, Brown MS, Zhong J, Mueller KF, Good W. NMR relaxation of water in hydrogel polymers: a model for tissue. Magn Reson Med 1989, 9:325-332.
123. Pilatus U, Ackerstaff E, Artemov D, Mori N, Gillies RJ, Bhujwalla ZM. Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber. Neoplasia 2000, 2:273-279.
124. Wu Y, Zhao P, Kiefer GE, Sherry AD. Multifunctional polymeric scaffolds for enhancement of PARACEST contrast sensitivity and performance: the effects of random copolymer variations. Macromolecules 2010, 43:6616-6624.
125. Banerjee R, Katsenovich Y, Lagos L, McIintosh M, Zhang X, Li CZ. Nanomedicine: magnetic nanoparticles and their biomedical applications. Curr Med Chem 2010, 17:3120-3141.
126. Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008, 29:4012-4021.
127. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003, 2:214-221.
128. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008, 3:703-717.
129. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
130. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004, 56:1649-1659.
131. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994, 31:1-8.
132. Bumb A, Brechbiel MW, Choyke P. Macromolecular and dendrimer-based magnetic resonance contrast agents. Acta Radiol 2010, 51:751-767.
133. Cormode DP, Jarzyna PA, Mulder WJ, Fayad ZA. Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev 2010, 62:329-338.
134. Bennett KM, Zhou H, Sumner JP, Dodd SJ, Bouraoud N, Doi K, Star RA, Koretsky AP. MRI of the basement membrane using charged nanoparticles as contrast agents. Magn Reson Med 2008, 60:564-574.
135. Beeman SC, Zhang M, Gubhaju L, Wu T, Bertram JF, Frakes DH, Cherry BR, Bennett KM. Measuring glomerular number and size in perfused kidneys using MRI. Am J Physiol Renal Physiol 2011, 300: F1454-F1457.
136. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, Chin S-F, Sherry AD, Boothman DA, Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006, 6:2427-2430.
137. Frias J, Williams K, Fisher E, Fayad ZA. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 2004, 126:16316-16317.
138. Handl HL, Sankaranarayanan R, Josan JS, Vagner J, Mash EA, Gillies RJ, Hruby VJ. Synthesis and evaluation of bivalent NDP-α-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R). Bioconjug Chem 2007, 18:1101-1109.
139. Li B, Martin AL, Gillies ER. Multivalent polymer vesicles via surface functionalization. Chem Commun (Camb) 2007, 48:734-741.
140. Xu L, Vagner J, Josan J, Lynch RM, Morse DL, Baggett B, Han H, Mash EA, Hruby VJ, Gillies RJ. Enhanced targeting with heterobivalent ligands. Mol Cancer Ther 2009, 8:2356-2365.
141. Xu L, Vagner J, Alleti R, Rao V, Jagadish B, Morse DL, Hruby VJ, Gillies RJ, Mash EA. Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors. Bioorg Med Chem Lett 2010, 20:2489-2492.
142. Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev 2008, 60:1209-1217.
143. Johansson BB. Experimental models of altering the blood brain barrier. Prog Brain Res 1992, 91: 171-175.
144. Kinoshita M. Targeted drug delivery to the brain using focused ultrasound. Top Magn Reson Imaging 2006, 17:209-215.
145. Liu CH, D'arceuil HE, De Crespigny AJ. Direct CSF injection of MnCl2 for dynamic manganese-enhanced MRI. Magn Reson Med 2004, 51:978-987.
146. Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, Wu JS, Tseng IC, Wang JJ, Yen TC, Chen PY, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A 2010, 107:15205-15210.
147. Madsen SJ, Hirschberg H. Site-specific opening of the blood-brain barrier. J Biophotonics 2010, 3:356-357.
148. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 1994, 91:2076.
149. Lonser RR, Walbridge S, Garmestani K, Butman JA, Walters HA, Vortmeyer AO, Morrison PF, Brechbiel MW, Oldfield EH. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg 2002, 97:905-913.
150. Veiseh O, Gunn JW, Zhang MQ. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010, 62:284-304.
151. Sperling RA, Parak WJ. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Transact A Math Phys Eng Sci 2010, 368:1333-1383.
152. Yiu HH, McBain SC, Lethbridge ZA, Lees MR, Dobson J. Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection. J Biomed Mater Res A 2010, 92:386-392.
153. Schellenberger E, Schnorr J, Reutelingsperger C, Ungethum L, Meyer W, Taupitz M, Hamm B. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. Small 2008, 4:225-230.
154. Yu MK, Jeong YY, Park J, Park S, Kim JW, Min JJ, Kim K, Jon S. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed Engl 2008, 47:5362-5365.
155. Dilnawaz F, Singh A, Mohanty C, Sahoo SK. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 2010, 31:3694-3706.
156. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003, 49:403-408.
157. Gunn J, Wallen H, Veiseh O, Sun C, Fang C, Cao J, Yee C, Zhang M. A multimodal targeting nanoparticle for selectively labeling T cells. Small 2008, 4:712-715.
158. Hermanson GT. Bioconjugate Techniques. London: Elsevier Inc; 2008.
159. Jolck RI, Feldborg LN, Andersen S, Moghimi SM, Andresen TL. Engineering liposomes and nanoparticles for biological targeting. Adv Biochem Eng Biotechnol 2011, 125:251-280.
160. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
161. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005, 23:1418-1423.
162. Schellenberger EA, Weissleder R, Josephson L. Optimal modification of annexin V with fluorescent dyes. Chembiochem 2004, 5:271-274.
163. Best MD. Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. Biochemistry 2009, 48:6571-6584.
164. Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed Engl 2001, 40:2004-2021.
165. Lutz JF, Zarafshani Z. Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne "click" chemistry. Adv Drug Deliv Rev 2008, 60:958-970.
166. Hein CD, Liu XM, Wang D. Click chemistry, a powerful tool for pharmaceutical sciences. Pharm Res 2008, 25:2216-2230.
167. von Maltzahn G, Ren Y, Park JH, Min DH, Kotamraju VR, Jayakumar J, Fogal V, Sailor MJ, Ruoslahti E, Bhatia SN. In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem 2008, 19:1570-1578.
168. Hogemann D, Josephson L, Weissleder R, Basilion JP. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem 2000, 11:941-946.
169. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L. Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 2004, 15:1062-1067.
170. Kohler N, Fryxell GE, Zhang M. A bifunctional poly (ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004, 126:7206-7211.
171. Sun C, Veiseh O, Gunn J, Fang C, Hansen S, Lee D, Sze R, Ellenbogen RG, Olson J, Zhang M. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4:372-379.
172. Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Sze R, Hallahan A, et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005, 5:1003-1008.
173. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007, 13:372-377.
174. Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L, Shaikh M, Yuet K, Cima MJ, Langer R, et al. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. Chem Med Chem 2008, 3:1311-1315.
175. Beaulac R, Schneider L, Archer PI, Bacher G, Gamelin DR. Light-induced spontaneous magnetization in doped colloidal quantum dots. Science 2009, 325:973-976.
176. Besombes L, Leger Y, Maingault L, Ferrand D, Mariette H, Cibert J. Probing the spin state of a single magnetic ion in an individual quantum dot. Phys Rev Lett 2004, 93:207403.
177. Reiter DE, Kuhn T, Axt VM. All-optical spin manipulation of a single manganese atom in a quantum dot. Phys Rev Lett 2009, 102:177403.
178. Bulte JW. In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 2009, 193:314-325.
179. Cromer Berman SM, Walczak P, Bulte JW. Tracking stem cells using magnetic nanoparticles. WIREs Nanomed Nanobiotechnol 2011, 3:343-355.
180. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003, 108:1009-1014.
181. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med 2006, 55:242-249.
182. Rodriguez O, Fricke S, Chien C, Dettin L, Van Meter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, et al. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle 2006, 5:113-119.
183. Nkansah MK, Thakral D, Shapiro EM. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking. Magn Reson Med 2011, 65: 1776-1785.
184. Tang KS, Shapiro EM. Enhanced magnetic cell labeling efficiency using -NH2 coated MPIOs. Magn Reson Med 2011, 65:1564-1569.
185. Heyn C, Ronald JA, Mackenzie LT, MacDonald IC, Chambers AF, Rutt BK, Foster PJ. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 2006, 55: 23-29.
186. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 2005, 53:329-338.
187. Long CM, van Laarhoven HW, Bulte JW, Levitsky HI. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res 2009, 69: 3180-3187.